Kiniksa Pharmaceuticals International PLC

Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.

Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.

Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.

Kiniksa Pharmaceuticals International PLC reported 196.03M in total liabilities as of the latest reported quarter, including 139.18M in current liabilities and 56.84M in non-current liabilities.

As of the latest reported quarter, Kiniksa Pharmaceuticals International PLC's total assets were 763.63M, consisting of 527.18M in current assets and 236.46M in non-current assets.

Kiniksa Pharmaceuticals International PLC reported 567.61M in total shareholders' equity as of the latest reported quarter.